Novel CXCR4 Inhibitor CPZ1344 Inhibits the Proliferation, Migration and Angiogenesis of Glioblastoma
- 6 July 2020
- journal article
- research article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 26 (4) , 2597-2604
Abstract
Glioblastoma (GBM) are life-threatening tumors with a poor prognosis and low cure rates. GBMs are malignant brain tumors that develop from astrocytes. Most GBMs are not inherited and occur sporadically. GBM recurrence after standard treatment has led to the assessment of agents targeting the CXCR4 chemokine receptor as alternative drug target for much needed GBM therapeutics. In present study, a novel CXCR4 inhibitor modified with a picolinamide scaffold (CPZ1344) was designed and synthesized. Its anti-GBM function was then evaluated. Our results showed that CPZ1344 reduced the growth of GBM cells in a concentration dependent manner. The anti-GBM activity of CPZ1344 was due to alteration in GBM-cell morphology and apoptotic induction in GBM cells. CPZ1344 inhibited the migration and angiogenesis of U87 cells, led to cell cycle arrest in the G1 phase and inhibited CXCR4 signaling. These findings demonstrate the anticancer effects of CPZ1344 and its potential as a novel anti-GBM therapeutic.Keywords
Funding Information
- Postdoctoral Research Foundation of China (2017M620196 and 2018T110467)
- National Natural Science Foundation of China (81772691 and 81370062)
This publication has 19 references indexed in Scilit:
- A comprehensive profile of recurrent glioblastomaOncogene, 2016
- Survival in glioblastoma: a review on the impact of treatment modalitiesClinical and Translational Oncology, 2016
- A Novel Approach to Block HIV-1 Coreceptor CXCR4 in Non-toxic MannerMolecular Biotechnology, 2014
- Glioblastoma and Other Malignant GliomasJAMA, 2013
- Development of a Unique Small Molecule Modulator of CXCR4PLOS ONE, 2012
- CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic targetBrain Tumor Pathology, 2011
- CXCR4 mediates the proliferation of glioblastoma progenitor cellsCancer Letters, 2009
- CXCR4 EXPRESSION IS ELEVATED IN GLIOBLASTOMA MULTIFORME AND CORRELATES WITH AN INCREASE IN INTENSITY AND EXTENT OF PERITUMORAL T2-WEIGHTED MAGNETIC RESONANCE IMAGING SIGNAL ABNORMALITIESNeurosurgery, 2008
- Discovery of Small Molecule CXCR4 AntagonistsJournal of Medicinal Chemistry, 2007
- A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumorsProceedings of the National Academy of Sciences, 2003